Injectable formulations containing a complex between progesterone and hydroxypropyl-betacyclodextrin

摘要

Formulation of injectable progesterone comprising a complex between progesterone and hydroxypropyl-β-cyclodextrin, characterized in that it contains an amount of unsubstituted β-cyclodextrin of less than 0.1% w / w on the amount of hydroxypropyl-β-cyclodextrin.